论文部分内容阅读
米非司酮是80年代开发并上市的口服抗早孕药物,米非司酮与极少量的前列腺素配伍对于妊娠49天以内的早孕妇女具有95％的完全流产率。根据Who人类生殖发展特别规划暑近年对米非司酮的临床研究,发现除应用于抗早孕以外同时还可应用于促宫颈成熟而作为人流前的扩宫药,月经延缓妇女的催经药,抗着床及事后避孕药,终止10—16周的中期妊娠以及抑制排卵的每日一次口服避孕药。
Mifepristone is an oral anti-pregnancy drug developed and marketed in the 1980s. Mifepristone, combined with a very small amount of prostaglandin, has a 95% complete abortion rate for early pregnant women within 49 days of gestation. According to the WHO human reproductive development special planning summer in recent years, mifepristone clinical research found that in addition to anti-early pregnancy can also be applied to promote cervical maturation and as a pre-abortion dilated drug, menstrual delay women’s drug, Anti-implantation and post-contraceptives, termination of 10-16 weeks of interim pregnancy and ovulation-inhibiting oral contraceptives.